The LDN Book, Volume Two - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook The LDN Book, Volume Two write by Linda Elsegood. This book was released on 2020-10-09. The LDN Book, Volume Two available in PDF, EPUB and Kindle. A comprehensive examination of Low Dose Naltrexone—a little-known drug with big potential "[LDN] raises hopes of reversing memory loss in old age."—the Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. LDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the immune response. Prescribed off-label and administered in small daily doses, this generic drug has proven useful in treating many different ailments. Expanding on the information presented in The LDN Book, Volume 1, which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue, Volume 2 highlights the latest clinical trials, case studies, and research with explanations from a dozen medical professionals on how they are using LDN to help patients suffering from: Chronic pain Parkinson’s disease Dermatologic conditions Traumatic brain injury Lyme disease and more The LDN Book, Volume 2 is both a resource for practitioners, pharmacists, and patients, and a renewed call for further research on the healing potential of this generic drug.
The Promise of Low Dose Naltrexone Therapy
The Promise of Low Dose Naltrexone Therapy - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook The Promise of Low Dose Naltrexone Therapy write by Elaine A. Moore. This book was released on 2009-01-22. The Promise of Low Dose Naltrexone Therapy available in PDF, EPUB and Kindle. Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
Classification of Chronic Pain
Classification of Chronic Pain - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Classification of Chronic Pain write by International Association for the Study of Pain. Task Force on Taxonomy. This book was released on 1994. Classification of Chronic Pain available in PDF, EPUB and Kindle. Le besoin d'un cadre taxonomique amène les auteurs à produire une classification codifiée des syndromes douloureux. Dans cette deuxième édition, différentes définitions de syndromes sont présentées.
Up the Creek with a Paddle
Up the Creek with a Paddle - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Up the Creek with a Paddle write by Mary Boyle Bradley. This book was released on 2009. Up the Creek with a Paddle available in PDF, EPUB and Kindle. "In 1986, when I first discovered LDN, if I had Mary Boyle Bradley on my team, this drug would have been approved, marketed and manufactured by a reputable pharmaceutical company. I have no doubt about that." Dr. Bernard Bihari The story is simple. It is about love, life and hope. After years of battling with the onslaught of her husband's Primary Progressive Multiple Sclerosis, Mary stumbled on a little known doctor in New York City, Dr. Bernard Bihari. Many people on the internet claimed that Dr. Bihari knew how to stop every type of MS from progressing. Even better, it was claimed that he could help everyone with an autoimmune disorder, ranging from psoriasis to AIDS. It was claimed that Dr. Bihari could help them with Low Dose Naltrexone (LDN). Eventually, Mary's husband took a leap of faith and put Dr. Bihari's work to the test. LDN worked. It stopped his MS from progressing. Since September 2002, a worldwide campaign has ignited with passionate momentum to get LDN medically recognized as a treatment for MS and all autoimmune disorders. LDN is a cheap, generic, out of patent drug with no known side-effects. Despite the fact that there is no financial incentive to entice any pharmaceutical company to investigate new uses for Naltrexone, the ambition is for LDN to hit the masses and improve the lives of millions. Small scale LDN clinical trials are finally making progress across the globe and are paving the way for a much better future for everyone who suffers from an autoimmune disorder.
The Power of Honest Medicine
The Power of Honest Medicine - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook The Power of Honest Medicine write by Julia Schopick. This book was released on 2018-10-15. The Power of Honest Medicine available in PDF, EPUB and Kindle. This book is about Low Dose Natlrexone, a low-cost treatment for autoimmune diseases such Crohn's, Fibromyalgia, Chronic Fatigue Syndrome, Rheumatoid Arthritis, MS, Lupus, etc. There are patient contributions from the US, UK and Europe
